Increased C-C chemokine receptor 2 gene expression in monocytes of severe obstructive sleep apnea patients and under intermittent hypoxia

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Chuang, Li Pang ^a,b   Chen, Ning Hung ^b   Lin, Shih Wei ^b   Chang, Ying Ling ^a   Liao, Hsiang Ruei ^a   Lin, Yu Sheng ^b   Chao, I Ju ^a   Lin, Yuling ^a   Pang, Jong Hwei S ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P42; PROTEIN P44; CCR2 PROTEIN, HUMAN;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD SAMPLING; CCR2 GENE; CELL ACTIVATION; CELL ADHESION ASSAY; CELL MIGRATION ASSAY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTERMITTENT HYPOXIA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEEP DISORDERED BREATHING; WESTERN BLOTTING; BLOOD; CELL ADHESION; CELL CULTURE; CELL HYPOXIA; CHEMOTAXIS; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; UPREGULATION;

ADULT; CELL ADHESION; CELL HYPOXIA; CELLS, CULTURED; CHEMOTAXIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, CCR2; SLEEP APNEA, OBSTRUCTIVE; UP-REGULATION;

EID: 84913588489     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113304     Document Type: Article

References (49)

1. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. American journal of respiratory and critical care medicine 165: 1217-1239.
2. (1994) Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944. Am J Respir Crit Care Med 150: 1738-1745.
3. Malhotra A, White DP (2002) Obstructive sleep apnoea. Lancet 360: 237-245.
4. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, et al. (2001) Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154: 50-59.
5. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, et al. (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97: 2154-2159.
6. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365: 1046-1053.
7. Nakashima H, Katayama T, Takagi C, Amenomori K, Ishizaki M, et al. (2006) Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J 27: 2317-2322.
8. Aboyans V, Cassat C, Lacroix P, Tapie P, Tabaraud F, et al. (2000) Is the morning peak of acute myocardial infarction's onset due to sleep-related breathing disorders? A prospective study. Cardiology 94: 188-192.
9. Gami AS, Howard DE, Olson EJ, Somers VK (2005) Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352: 1206-1214.
10. Parker JD, Brooks D, Kozar LF, Render-Teixeira CL, Horner RL, et al. (1999) Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160: 1888-1896.
11. Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98: 2269-2275.
12. Nacher M, Farre R, Montserrat JM, Torres M, Navajas D, et al. (2009) Biological consequences of oxygen desaturation and respiratory effort in an acute animal model of obstructive sleep apnea (OSA). Sleep medicine 10: 892-897.
13. Ryan S, McNicholas WT (2008) Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. Archives of physiology and biochemistry 114: 261-266.
14. Hansson GK (2009) Inflammatory mechanisms in atherosclerosis. Journal of thrombosis and haemostasis: JTH 7 Suppl 1: 328-331.
15. Amasyali B, Kose S, Kursaklioglu H, Barcin C, Kilic A (2009) Monocyte chemoattractant protein-1 in acute coronary syndromes: complex vicious interaction. International journal of cardiology 136: 356-357.
16. Tieu BC, Lee C, Sun H, Lejeune W, Recinos A 3rd, et al. (2009) An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. The Journal of clinical investigation 119: 3637-3651.
17. Green SR, Han KH, Chen Y, Almazan F, Charo IF, et al. (2006) The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. Journal of immunology 176: 7412-7420.
18. Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M (2004) MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway. Life sciences 75: 1333-1341.
19. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, et al. (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proceedings of the National Academy of Sciences of the United States of America 94: 12053-12058.
20. Kaditis AG, Alexopoulos EI, Karathanasi A, Ntamagka G, Oikonomidi S, et al. (2010) Adiposity and low-grade systemic inflammation modulate matrix metalloproteinase-9 levels in Greek children with sleep apnea. Pediatr Pulmonol 45: 693-699.
21. Yamashita C, Hayashi T, Mori T, Matsumoto C, Kitada K, et al. (2010) Efficacy of olmesartan and nifedipine on recurrent hypoxia-induced left ventricular remodeling in diabetic mice. Life Sci 86: 322-330.
22. Tamaki S, Yamauchi M, Fukuoka A, Makinodan K, Koyama N, et al. (2009) Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern Med 48: 1255-1262.
23. Chuang LP, Chen NH, Lin SW, Chang YL, Chao IJ, et al. (2013) Increased matrix metalloproteinases-9 after sleep in plasma and in monocytes of obstructive sleep apnea patients. Life Sci 93: 220-225.
24. Dyugovskaya L, Polyakov A, Lavie P, Lavie L (2008) Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 177: 544-554.
25. Chuang SY, Yang SH, Pang JH (2011) Cilostazol reduces MCP-1-induced chemotaxis and adhesion of THP-1 monocytes by inhibiting CCR2 gene expression. Biochem Biophys Res Commun 411: 402-408.
26. Ko J, Yun CY, Lee JS, Kim JH, Kim IS (2007) p38 MAPK and ERK activation by 9-cis-retinoic acid induces chemokine receptors CCR1 and CCR2 expression in human monocytic THP-1 cells. Exp Mol Med 39: 129-138.
27. Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, et al. (2003) Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 111: 1185-1199; quiz 1200.
28. Murphy N, Bruckdorfer KR, Grimsditch DC, Overend P, Vidgeon-Hart M, et al. (2003) Temporal relationships between circulating levels of CC and CXC chemokines and developing atherosclerosis in apolipoprotein E3 Leiden mice. Arterioscler Thromb Vasc Biol 23: 1615-1620.
29. Boring L, Gosling J, Cleary M, Charo IF (1998) Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897.
30. Han KH, Tangirala RK, Green SR, Quehenberger O (1998) Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. Arterioscler Thromb Vasc Biol 18: 1983-1991.
31. Inoue S, Egashira K, Ni W, Kitamoto S, Usui M, et al. (2002) Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106: 2700-2706.
32. Olzinski AR, Turner GH, Bernard RE, Karr H, Cornejo CA, et al. (2010) Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/ apolipoprotein E-/- mouse: magnetic resonance imaging assessment. Arterioscler Thromb Vasc Biol 30: 253-259.
33. Ni W, Kitamoto S, Ishibashi M, Usui M, Inoue S, et al. (2004) Monocyte chemoattractant protein-1 is an essential inflammatory mediator in angiotensin II-induced progression of established atherosclerosis in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 24: 534-539.
34. Okumoto S, Taniguchi Y, Nakashima A, Masaki T, Ito T, et al. (2009) C-C chemokine receptor 2 expression by circulating monocytes influences atherosclerosis in patients on chronic hemodialysis. Ther Apher Dial 13: 205-212.
35. Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7: 677-685.
36. Nanduri J, Yuan G, Kumar GK, Semenza GL, Prabhakar NR (2008) Transcriptional responses to intermittent hypoxia. Respir Physiol Neurobiol 164: 277-281.
37. Morgan BJ (2007) Vascular consequences of intermittent hypoxia. Adv Exp Med Biol 618: 69-84.
38. Lavie L, Dyugovskaya L, Polyakov A (2008) Biology of peripheral blood cells in obstructive sleep apnea-the tip of the iceberg. Arch Physiol Biochem 114: 244-254.
39. Lam SY, Liu Y, Ng KM, Lau CF, Liong EC, et al. (2012) Chronic intermittent hypoxia induces local inflammation of the rat carotid body via functional upregulation of proinflammatory cytokine pathways. Histochem Cell Biol 137: 303-317.
40. Lavie L (2003) Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7: 35-51.
41. Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, et al. (2004) Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126: 1473-1479.
42. Lavie L, Dyugovskaya L, Lavie P (2005) Sleep-apnea-related intermittent hypoxia and atherogenesis: adhesion molecules and monocytes/endothelial cells interactions. Atherosclerosis 183: 183-184.
43. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165: 934-939.
44. Lattimore JD, Wilcox I, Nakhla S, Langenfeld M, Jessup W, et al. (2005) Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. Atherosclerosis 179: 255-259.
45. Glass CK, Witztum JL (2001) Atherosclerosis. the road ahead. Cell 104: 503-516.
46. Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, et al. (2000) Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31: 40-47.
47. Yamashita A, Ishida K, Aratake K, Wakamatsu H, Kawata R, et al. (2000) [Perioperative management of endovascular stent graft placement for abdominal aortic aneurysm]. Masui 49: 987-994.
48. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, et al. (1994) Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90: 775-778.
49. Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijn DP, Teepen H, et al. (2000) Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150: 245-253.